Drug
Pimicotinib
Pimicotinib: highest development phase Phase 2, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pimicotinib NCT07499362 | Phase 2 | Tenosynovial Giant Cell Tumor |
Latest
No recent events.
Follow Pimicotinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.